1. Ketamine versus dexmedetomidine as an adjuvant in ultrasound-guided supraclavicular brachial plexus block: a double-blind randomized clinical trial
- Author
-
Mohamed A.A Ahmed, Ahmed H Mohmed, Abeer A.M Hassanein, and Haidy S Mansour
- Subjects
Bupivacaine ,Visual analogue scale ,business.industry ,Analgesic ,law.invention ,medicine.anatomical_structure ,Randomized controlled trial ,Forearm ,law ,Anesthesia ,medicine ,General Earth and Planetary Sciences ,Ketamine ,Dexmedetomidine ,business ,medicine.drug ,Brachial plexus block - Abstract
Background Peripheral nerve block has gained increased popularity owing to less postoperative pain and reduced need for postoperative analgesic drugs. The aim of the study was to compare the effect of ketamine and dexmedetomidine on the supraclavicular nerve block. Patients and methods A total of 75 adult patients undergoing elective operations of the elbow, forearm, wrist, or hand were randomly allocated into three groups of 25 patients each. Group K (ketamine group) received 40 ml 0.25% bupivacaine contain 1 mg/kg ketamine, group D (dexmedetomidine group) received 40 ml 0.25% bupivacaine contain 1 μg/kg dexmedetomidine, and group C (control group) received 40 ml 0.25% bupivacaine. The outcome measures included visual analog scale (0=no pain and 10 cm=the most severe pain), time to first analgesic request, and total dose of diclofenac analgesia given postoperatively. Results Patients in D and K groups had reduced visual analog scale scores than the C group, at all time points after surgery during the first 24 h, with more reduction in group D than K group (P Conclusion The addition of ketamine or dexmedetomidine in the ultrasound-guided supraclavicular brachial plexus block could improve the postoperative pain and need for analgesia. Therefore, we can consider the low-price readily available ketamine as a comparable adjuvant in brachial plexus block to some extent as dexmedetomidine.
- Published
- 2021
- Full Text
- View/download PDF